Free weekly newsletter
Get the free weekly contract digest
The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Jupiter Bioventures Announces $70 Million Funding for Biotechnology Venture Foundry
Nov 19, 2024•over 1 year ago
Contract Type
partnership
San FranciscoBiotechnologyDescription
Jupiter Bioventures, a biotechnology venture foundry, has announced the closing of a $70 million initial financing round. Co-founders Nathaniel “Ned” David, PhD, and Norman “Ned” Sharpless, MD, aim to use the funding to evaluate, found, and operate biotech companies focusing on unmet needs in cancer and disease areas where cancer biology provides insight.
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months